Liu Chun-Yi, Lee Cheng-Feng, Wei Yau-Huei
Institute of Biochemistry and Molecular Biology, School of Life Sciences, National Yang-Ming University, Taipei, Taiwan.
J Formos Med Assoc. 2009 Aug;108(8):599-611. doi: 10.1016/s0929-6646(09)60380-6.
A wide spectrum of pathogenic mutations of mitochondrial DNA (mtDNA) has been demonstrated to cause mitochondrial dysfunction and overproduction of reactive oxygen species (ROS), in relation to mitochondrial and neurodegenerative diseases. Our previous studies have shown that large-scale deletions of mtDNA not only serve as an indicator of oxidative damage, but also result in greater susceptibility of human cells to apoptosis triggered by UV irradiation and other apoptotic stimuli. In this review, we focus on the involvement of mtDNA-mutation-associated oxidative stress and susceptibility to apoptosis in the pathophysiology of mitochondrial and neurodegenerative diseases. Different lines of research have provided concordant data to suggest that the mtDNA-mutation-elicited energy insufficiency and enhanced oxidative stress and damage lead to cell dysfunction, and increase the susceptibility of affected cells to apoptosis in patients with these diseases. Moreover, accumulating experimental evidence has shown that antioxidant therapy is a good strategy for decreasing intracellular ROS and alleviating oxidative-stress-induced apoptosis in cells of patients that harbor pathogenic mtDNA mutations.
线粒体DNA(mtDNA)的广泛致病性突变已被证明会导致线粒体功能障碍和活性氧(ROS)的过度产生,这与线粒体疾病和神经退行性疾病有关。我们之前的研究表明,mtDNA的大规模缺失不仅是氧化损伤的一个指标,还会导致人类细胞对紫外线照射和其他凋亡刺激引发的凋亡更敏感。在这篇综述中,我们关注与mtDNA突变相关的氧化应激以及凋亡易感性在线粒体疾病和神经退行性疾病病理生理学中的作用。不同的研究方向提供了一致的数据,表明mtDNA突变引发的能量不足以及氧化应激和损伤的增强会导致细胞功能障碍,并增加这些疾病患者受影响细胞对凋亡的易感性。此外,越来越多的实验证据表明,抗氧化治疗是一种降低细胞内ROS水平并减轻携带致病性mtDNA突变患者细胞中氧化应激诱导凋亡的良好策略。